Andrew Evans

4.1k total citations
42 papers, 1.9k citations indexed

About

Andrew Evans is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Surgery. According to data from OpenAlex, Andrew Evans has authored 42 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 10 papers in Epidemiology and 8 papers in Surgery. Recurrent topics in Andrew Evans's work include Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Acute Ischemic Stroke Management (9 papers). Andrew Evans is often cited by papers focused on Prostate Cancer Treatment and Research (11 papers), Prostate Cancer Diagnosis and Treatment (10 papers) and Acute Ischemic Stroke Management (9 papers). Andrew Evans collaborates with scholars based in Canada, United Kingdom and United States. Andrew Evans's co-authors include Lalit Kalra, Iñigo Perez, Martín Knapp, Nora Donaldson, Anita Patel, Anne Melbourn, Lalit Kalra, F Harraf, Ants Toi and Antonio Finelli and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Andrew Evans

41 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew Evans Canada 23 689 598 522 288 243 42 1.9k
Klaus Kraywinkel Germany 24 802 1.2× 622 1.0× 310 0.6× 120 0.4× 67 0.3× 127 2.0k
Jipan Xie United States 24 304 0.4× 370 0.6× 173 0.3× 232 0.8× 393 1.6× 133 2.4k
James E. Siegler United States 25 1.2k 1.8× 539 0.9× 377 0.7× 294 1.0× 67 0.3× 164 2.0k
Dörte Huscher Germany 38 566 0.8× 1.5k 2.6× 83 0.2× 732 2.5× 134 0.6× 137 4.4k
Jeffrey J. Wing United States 21 490 0.7× 129 0.2× 203 0.4× 113 0.4× 95 0.4× 63 1.5k
JoRean D. Sicks United States 21 1.4k 2.0× 1.9k 3.2× 245 0.5× 1.1k 3.7× 89 0.4× 47 3.3k
Lene Dreyer Denmark 37 359 0.5× 363 0.6× 40 0.1× 208 0.7× 350 1.4× 172 4.4k
Ya Ruth Huo Australia 26 400 0.6× 559 0.9× 44 0.1× 119 0.4× 198 0.8× 50 2.0k
Anne Gulbech Ording Denmark 21 325 0.5× 251 0.4× 34 0.1× 415 1.4× 136 0.6× 90 1.6k
Sunni A. Barnes United States 31 264 0.4× 238 0.4× 129 0.2× 409 1.4× 44 0.2× 67 2.8k

Countries citing papers authored by Andrew Evans

Since Specialization
Citations

This map shows the geographic impact of Andrew Evans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew Evans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew Evans more than expected).

Fields of papers citing papers by Andrew Evans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew Evans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew Evans. The network helps show where Andrew Evans may publish in the future.

Co-authorship network of co-authors of Andrew Evans

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew Evans. A scholar is included among the top collaborators of Andrew Evans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew Evans. Andrew Evans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Williams, AnnaLynn M., Andrea Baran, Patrick M. Reagan, et al.. (2020). Toxicity patterns of novel PI3K combinations in patients with non-Hodgkin lymphoma. Leukemia & lymphoma. 62(3). 598–605. 1 indexed citations
2.
Silsby, Matthew, et al.. (2019). Time to acute stroke treatment in‐hours was more than halved after the introduction of the Helsinki Model at Westmead Hospital. Internal Medicine Journal. 49(11). 1386–1392. 6 indexed citations
3.
4.
Sayyid, Rashid K., Andrew Evans, Karen Hersey, et al.. (2016). A Phase II, Randomized, Open-Label Study of Neoadjuvant Degarelix versus LHRH Agonist in Prostate Cancer Patients Prior to Radical Prostatectomy. Clinical Cancer Research. 23(8). 1974–1980. 34 indexed citations
5.
Vachhani, Pankit, Jason H. Mendler, Andrew Evans, et al.. (2016). Spontaneous Remission in an Older Patient with RelapsedFLT3ITD Mutant AML. SHILAP Revista de lepidopterología. 2016. 1–7. 11 indexed citations
6.
Bhindi, Bimal, David Margel, Greg Trottier, et al.. (2013). Obesity Is Associated With Larger Prostate Volume but not With Worse Urinary Symptoms: Analysis of a Large Multiethnic Cohort. Urology. 83(1). 81–87. 22 indexed citations
7.
Yoshimoto, Maisa, Olga Ludkovski, Jennifer Good, et al.. (2013). Abstract 63: Incorporation of flanking probes reduces truncation losses for fluorescence in situ hybridization analysis of recurrent genomic deletions in tumor sections.. Cancer Research. 73(8_Supplement). 63–63. 3 indexed citations
8.
9.
Crook, Juanita, Jette Borg, Andrew Evans, et al.. (2010). 10-Year Experience With I-125 Prostate Brachytherapy at the Princess Margaret Hospital: Results for 1,100 Patients. International Journal of Radiation Oncology*Biology*Physics. 80(5). 1323–1329. 91 indexed citations
10.
Markus, Hugh S., Usman Khan, Jonathan Birns, et al.. (2007). Differences in Stroke Subtypes Between Black and White Patients With Stroke. Circulation. 116(19). 2157–2164. 105 indexed citations
11.
Fleshner, Neil, Leonard G. Gomella, Michael S. Cookson, et al.. (2007). Delay in the progression of low-risk prostate cancer: Rationale and design of the Reduction by Dutasteride of Clinical Progression Events in Expectant Management (REDEEM) trial. Contemporary Clinical Trials. 28(6). 763–769. 54 indexed citations
12.
Rowsell, Corwyn, Neil Fleshner, Paula Marrano, Jeremy A. Squire, & Andrew Evans. (2007). Papillary renal cell carcinoma within a renal oncocytoma: case report of an incidental finding of a tumour within a tumour. Journal of Clinical Pathology. 60(4). 426–428. 22 indexed citations
13.
Volpe, Alessandro, John R. Kachura, Andrew Evans, et al.. (2006). 1108: Techniques, Safety and Accuracy of Needle Biopsy of Renal Tumors. The Journal of Urology. 175(4S). 356–357. 1 indexed citations
14.
O’Connor, Owen A., James R. Wright, Craig H. Moskowitz, et al.. (2004). A Multicenter Experience with Single Agent Bortezomib in Non-Hodgkin’s Lymphoma Reveals Marked Differences in Sub-Type Sensitivity to Proteasome Inhibition.. Blood. 104(11). 607–607. 16 indexed citations
15.
Patel, Anita, Martín Knapp, Andrew Evans, Iñigo Perez, & Lalit Kalra. (2004). Training care givers of stroke patients: economic evaluation. BMJ. 328(7448). 1102–1102. 98 indexed citations
16.
Jerrard-Dunne, Paula, Andrew Evans, Rory McGovern, et al.. (2003). Ethnic Differences in Markers of Thrombophilia. Stroke. 34(8). 1821–1826. 51 indexed citations
17.
Evans, Andrew & Lalit Kalra. (2001). Are the Results of Randomized Controlled Trials on Anticoagulation in Patients With Atrial Fibrillation Generalizable to Clinical Practice?. Archives of Internal Medicine. 161(11). 1443–1443. 87 indexed citations
18.
Evans, Andrew, Iñigo Perez, F Harraf, et al.. (2001). Can differences in management processes explain different outcomes between stroke unit and stroke-team care?. The Lancet. 358(9293). 1586–1592. 132 indexed citations
19.
Kalra, Lalit, Andrew Evans, Iñigo Perez, et al.. (2000). Alternative strategies for stroke care: a prospective randomised controlled trial. The Lancet. 356(9233). 894–899. 159 indexed citations
20.
Evans, Andrew, et al.. (1999). Bilateral Lymphangiomas of the Ovary. International Journal of Gynecological Pathology. 18(1). 87–90. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Klaus Kraywinkel Breakdown of academic impact, for papers by Jipan Xie Breakdown of academic impact, for papers by James E. Siegler Breakdown of academic impact, for papers by Dörte Huscher Breakdown of academic impact, for papers by Jeffrey J. Wing Breakdown of academic impact, for papers by JoRean D. Sicks Breakdown of academic impact, for papers by Lene Dreyer Breakdown of academic impact, for papers by Ya Ruth Huo Breakdown of academic impact, for papers by Anne Gulbech Ording Breakdown of academic impact, for papers by Sunni A. Barnes
Rankless by CCL
2026